Neurotech International Limited announced that Brian Leedman has been appointed Non-executive Chairman effective immediately. Mr. Leedman is the founder and former director of a number of ASX listed biotechnology companies that have achieved large returns for shareholders. Concurrently Mr. Peter Griffiths has transitioned from his role as a director of the Company to Chief Executive Officer of the Company's Maltese subsidiary AAT Research Ltd. overseeing the Company's Mente program, and Dr. David Cantor has retired from the Board of the Company. Mr. Leedman is formerly the Chairman (WA) of Ausbiotech, Founder and Executive Director of ResApp Health, Founder of Oncosil Medical and Biolife Sciences Limited (acquired by Imugene Limited) and Non-executive Director of Alcidion Corporation. He is presently the Chairman or NeuroScientific Biopharmaceuticals and Chairman of Nutritional Growth Solutions.